EAST.V · EastWest Bioscience Inc

-

Please sign in to comment on EAST.V

1 Comment

Admin

4 years, 1 month ago

EastWest Bioscience Inc is currently in a long term downtrend where the price is trading 13.8% below its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.

EastWest Bioscience Inc's total revenue sank by 35.8% to $172K since the same quarter in the previous year.

Its net income has dropped by 638.8% to $-311K since the same quarter in the previous year.

Finally, its free cash flow fell by 285.8% to $-197K since the same quarter in the previous year.

Based on the above factors, EastWest Bioscience Inc gets an overall score of 1/5.

Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
ISIN	CA27783V1076
Exchange	V
CurrencyCode	CAD

Beta	0.7
Market Cap	3M
PE Ratio	0.02
Dividend Yield	0.0%
Target Price	461.63

ABOUT

EastWest Bioscience Inc

EastWest Bioscience Inc., a vertically-integrated wellness company, engages in the manufacturing and sale of hemp nutritional products in Canada and the United States. The company also operates Sangster's Health Center stores that sells supplements and wellness products through its franchise locations and online ecommerce platform. In addition, it is involved in the property management business. The company was founded in 2016 and is headquartered in Penticton, Canada.

EAST.V · EastWest Bioscience Inc

-

EastWest Bioscience Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest EastWest Bioscience Inc using a moving average strategy